Advertisement
U.S. markets open in 6 hours 34 minutes
  • S&P Futures

    5,114.50
    +10.75 (+0.21%)
     
  • Dow Futures

    39,071.00
    +28.00 (+0.07%)
     
  • Nasdaq Futures

    18,154.00
    +71.25 (+0.39%)
     
  • Russell 2000 Futures

    2,059.40
    +2.10 (+0.10%)
     
  • Crude Oil

    78.43
    +0.17 (+0.22%)
     
  • Gold

    2,055.20
    +0.50 (+0.02%)
     
  • Silver

    22.69
    +0.03 (+0.13%)
     
  • EUR/USD

    1.0817
    +0.0009 (+0.09%)
     
  • 10-Yr Bond

    4.2520
    0.0000 (0.00%)
     
  • Vix

    13.40
    -0.44 (-3.18%)
     
  • GBP/USD

    1.2635
    +0.0009 (+0.07%)
     
  • USD/JPY

    150.4820
    +0.4980 (+0.33%)
     
  • Bitcoin USD

    61,561.64
    -1,054.08 (-1.68%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • FTSE 100

    7,630.02
    +5.04 (+0.07%)
     
  • Nikkei 225

    39,910.82
    +744.63 (+1.90%)
     

Quipt Home Medical Corp. to Announce Fourth Quarter and Full Year 2023 Financial Results on December 18, 2023

CINCINNATI, Dec. 05, 2023 (GLOBE NEWSWIRE) -- Quipt Home Medical Corp. (the “Company”) (NASDAQ: QIPT) (TSX: QIPT), a U.S. based home medical equipment provider, focused on end-to-end respiratory care, will announce its fourth quarter and full year 2023 financial results on Monday, December 18, 2023. Gregory Crawford, Chief Executive Officer, and Hardik Mehta, Chief Financial Officer, will host a conference call for the investment community on Tuesday, December 19, 2023, at 10:00 a.m. (ET).

The call-in numbers for participants are:

 

 

 

 

 

Canada/US Toll Free:

 

1 (800) 319 4610

 

International:

 

1 (604) 638 5340


A live webcast of the call will be accessible via the investor section of the Company’s website through the following link: www.quipthomemedical.com.

ABOUT QUIPT HOME MEDICAL

The Company provides in-home monitoring and disease management services including end-to-end respiratory solutions for patients in the United States healthcare market. It seeks to continue to expand its offerings to include the management of several chronic disease states focusing on patients with heart or pulmonary disease, sleep disorders, reduced mobility and other chronic health conditions. The primary business objective of the Company is to create shareholder value by offering a broader range of services to patients in need of in-home monitoring and chronic disease management. The Company’s organic growth strategy is to increase annual revenue per patient by offering multiple services to the same patient, consolidating the patient’s services and making life easier for the patient.

For further information please visit our website at www.quipthomemedical.com, or contact:

Cole Stevens
VP of Corporate Development
Quipt Home Medical Corp.
859-300-6455
cole.stevens@myquipt.com

Gregory Crawford
Chief Executive Officer
Quipt Home Medical Corp.
859-300-6455
investorinfo@myquipt.com


Advertisement